# China NMPA Drug Inspection - Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch - Amoxicillin Clavulanate Potassium Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhuhai-federal-pharmaceutical-co-ltd-zhongshan-branch/7082e61e-8c47-4a50-a5a4-35f22cff56ad/
Source feed: China

> China NMPA drug inspection for Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch published June 17, 2021. Drug: Amoxicillin Clavulanate Potassium Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 5, 2021)
- Company Name: Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch
- Publication Date: 2021-06-17
- Drug Name: Amoxicillin Clavulanate Potassium Tablets
- Inspection Finding: Compliant with drug standards

Company: https://www.globalkeysolutions.net/companies/zhuhai-federal-pharmaceutical-co-ltd-zhongshan-branch/c59a9b54-d48f-4da4-8915-1d5df13879f7/